NEW YORK, July 16 - Wyeth-Ayerst Laboratories has extended its genomics research collaboration with Genome Therapeutics for at least an additional 18 months, Genome Therapeutics said Monday. 

The joint research project, to develop osteoporosis treatments using targets found by characterizing a gene associated with high bone mass, will now continue until at least December 2002. Genome Therapeutics recently received a milestone payment from Wyeth-Ayerst for its research progress, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.